Evidence on SGLT2 Inhibitors' Efficacy in Older and Frail Patients.

The study also showed a trend towards a reduction in muscle mass, skeletal muscle mass, lean body mass, bone mineral content and handgrip strength; however, these findings did not reach statistical significance [ 12 ].

also in 53,322 other papers